Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1Bortezomib/dexamethasone
(Maxidex (TN))		2件: Bortezomib,
Dexamethasone (Maxidex)		2件: Dexamethasone (Maxidex (TN)),
Bortezomib 💬 		2件: NR3C1,
PSMB5 💬 		9件: Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Neuroactive ligand-receptor interaction, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬1件: 283 💬
2Bortezomib/Dexamethasone (BD), Followed By Autologous STC & Maintenance Bortezomib/Dexamethasone
(Maxidex (TN))		2件: Bortezomib,
Dexamethasone (Maxidex)		2件: Dexamethasone (Maxidex (TN)),
Bortezomib 💬 		2件: NR3C1,
PSMB5 💬 		9件: Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Neuroactive ligand-receptor interaction, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬1件: 28 💬
3Bupivacaine/epinephrine/dexamethasone
(Maxidex (TN))		3件: Bupivacaine,
Dexamethasone (Maxidex),
Epinephrine		3件: Epinephrine ,
Dexamethasone (Maxidex (TN)),
Bupivacaine 💬 		15件: ADRA1A,
ADRA1B,
ADRA1D,
ADRA2A,
ADRA2B,
ADRA2C,
ADRB1,
ADRB2,
ADRB3,
NR3C1,
SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬 		16件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Taste transduction, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 96 💬
4Combination of Protein A Immunoadsorption, Rituximab, Dexamethasone plus Azathioprine
(Maxidex (TN))		3件: Azathioprine,
Dexamethasone (Maxidex),
Rituximab		3件: Azathioprine ,
Dexamethasone (Maxidex (TN)),
Rituximab 💬 		2件: MS4A1,
NR3C1 💬 		2件: Hematopoietic cell lineage, Neuroactive ligand-receptor interaction 💬1件: 35 💬
5Control intervention (no dexamethasone)
(Maxidex (TN))		1件: Dexamethasone (Maxidex)1件: Dexamethasone (Maxidex (TN)) 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 46 💬
6Conventional Glucocorticoids (immediate release hydrocortisone, cortisone acetate, prednisone, prednisolone, dexamethasone)
(Maxidex (TN))		7件: Acetate,
Cortisone,
Cortisone acetate,
Dexamethasone (Maxidex),
Hydrocortisone,
Prednisolone,
Prednisone		6件: Hydrocortisone ,
Dexamethasone (Maxidex (TN)),
Prednisolone ,
Prednisone ,
Cortisone acetate ,
Cortisone 💬 		1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 81 💬
7Cyclophosphamide, bortezomib, and Dexamethasone (CyBorD) regimen
(Maxidex (TN))		3件: Bortezomib,
Cyclophosphamide,
Dexamethasone (Maxidex)		4件: Cyclophosphamide ,
Dexamethasone (Maxidex (TN)),
Bortezomib ,
Cyclophosphamide 💬 		2件: NR3C1,
PSMB5 💬 		9件: Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Neuroactive ligand-receptor interaction, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬1件: 28 💬
8Cyclophosphamide, Bortezomib, dexamethasone
(Maxidex (TN))		3件: Bortezomib,
Cyclophosphamide,
Dexamethasone (Maxidex)		4件: Cyclophosphamide ,
Dexamethasone (Maxidex (TN)),
Bortezomib ,
Cyclophosphamide 💬 		2件: NR3C1,
PSMB5 💬 		9件: Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Neuroactive ligand-receptor interaction, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬1件: 28 💬
9Cyclophosphamide, Bortezomib, dexamethasone plus Daratumumab
(Maxidex (TN))		4件: Bortezomib,
Cyclophosphamide,
Daratumumab,
Dexamethasone (Maxidex)		5件: Cyclophosphamide ,
Dexamethasone (Maxidex (TN)),
Bortezomib ,
Cyclophosphamide ,
Daratumumab 💬 		3件: CD38,
NR3C1,
PSMB5 💬 		16件: Alzheimer disease, Amyotrophic lateral sclerosis, Calcium signaling pathway, Hematopoietic cell lineage, Huntington disease, Metabolic pathways, Neuroactive ligand-receptor interaction, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Salivary secretion, Spinocerebellar ataxia 💬1件: 28 💬
10Dexamethasone
(Maxidex (TN))		1件: Dexamethasone (Maxidex)1件: Dexamethasone (Maxidex (TN)) 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬22件: 13, 14, 16, 28, 35, 46, 53, 63, 64, 65, 70, 81, 84, 96, 97, 162, 222, 235, 257, 283, 296, 299 💬
11Dexamethasone (1 cycle)
(Maxidex (TN))		1件: Dexamethasone (Maxidex)1件: Dexamethasone (Maxidex (TN)) 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 63 💬
12Dexamethasone (4 cycles)
(Maxidex (TN))		1件: Dexamethasone (Maxidex)1件: Dexamethasone (Maxidex (TN)) 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 63 💬
13Dexamethasone (50mg 1dd6, 3 consecutive days/month)
(Maxidex (TN))		1件: Dexamethasone (Maxidex)1件: Dexamethasone (Maxidex (TN)) 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 35 💬
14Dexamethasone (or equivalent)
(Maxidex (TN))		1件: Dexamethasone (Maxidex)1件: Dexamethasone (Maxidex (TN)) 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 257 💬
15Dexamethasone 0,1 mg Tablets
(Maxidex (TN))		1件: Dexamethasone (Maxidex)1件: Dexamethasone (Maxidex (TN)) 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 81 💬
16Dexamethasone 0,5mg
(Maxidex (TN))		1件: Dexamethasone (Maxidex)1件: Dexamethasone (Maxidex (TN)) 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 84 💬
17Dexamethasone 0.5mg Tablet
(Maxidex (TN))		1件: Dexamethasone (Maxidex)1件: Dexamethasone (Maxidex (TN)) 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 81 💬
18Dexamethasone 0.5mg/5ml solution
(Maxidex (TN))		1件: Dexamethasone (Maxidex)1件: Dexamethasone (Maxidex (TN)) 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬2件: 35, 162 💬
19Dexamethasone 0.5mg/5ml solution in Mucolox™
(Maxidex (TN))		1件: Dexamethasone (Maxidex)1件: Dexamethasone (Maxidex (TN)) 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬2件: 35, 162 💬
20Dexamethasone 1,5 mg Tablets
(Maxidex (TN))		1件: Dexamethasone (Maxidex)1件: Dexamethasone (Maxidex (TN)) 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 81 💬
21Dexamethasone 21-dihydrogen phosphate
(Maxidex (TN))		3件: Dexamethasone (Maxidex),
Hydrogen,
Phosphate ion		1件: Dexamethasone (Maxidex (TN)) 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 65 💬
22Dexamethasone 21-phosphate
(Maxidex (TN))		2件: Dexamethasone (Maxidex),
Phosphate ion		1件: Dexamethasone (Maxidex (TN)) 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 97 💬
23Dexamethasone 2mg Tablets
(Maxidex (TN))		1件: Dexamethasone (Maxidex)1件: Dexamethasone (Maxidex (TN)) 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 81 💬
24Dexamethasone 4 mg JENAPHARM
(Maxidex (TN))		1件: Dexamethasone (Maxidex)1件: Dexamethasone (Maxidex (TN)) 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 28 💬
25Dexamethasone Abcur
(Maxidex (TN))		1件: Dexamethasone (Maxidex)1件: Dexamethasone (Maxidex (TN)) 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 63 💬
26Dexamethasone and Rituximab
(Maxidex (TN))		2件: Dexamethasone (Maxidex),
Rituximab		2件: Dexamethasone (Maxidex (TN)),
Rituximab 💬 		2件: MS4A1,
NR3C1 💬 		2件: Hematopoietic cell lineage, Neuroactive ligand-receptor interaction 💬1件: 63 💬
27Dexamethasone given orally
(Maxidex (TN))		1件: Dexamethasone (Maxidex)1件: Dexamethasone (Maxidex (TN)) 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 13 💬
28Dexamethasone oral tablet 8mg (Dexamethasone Krka tablets(8mg), Warsaw, Poland).
(Maxidex (TN))		1件: Dexamethasone (Maxidex)1件: Dexamethasone (Maxidex (TN)) 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 235 💬
29Dexamethasone Oral, 10 mg
(Maxidex (TN))		1件: Dexamethasone (Maxidex)1件: Dexamethasone (Maxidex (TN)) 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 28 💬
30Dexamethasone Oral, 20 mg
(Maxidex (TN))		1件: Dexamethasone (Maxidex)1件: Dexamethasone (Maxidex (TN)) 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 28 💬
31Dexamethasone Parotid Irrigation
(Maxidex (TN))		1件: Dexamethasone (Maxidex)1件: Dexamethasone (Maxidex (TN)) 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 53 💬
32DEXAMETHASONE SODIUM PHOSPHATE
(Maxidex (TN))		2件: Dexamethasone (Maxidex),
Phosphate ion		1件: Dexamethasone (Maxidex (TN)) 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬3件: 65, 70, 96 💬
33Dexamethasone sodium phosphate (soluzione 25mg/ml)
(Maxidex (TN))		2件: Dexamethasone (Maxidex),
Phosphate ion		1件: Dexamethasone (Maxidex (TN)) 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 65 💬
34Dexamethasone sodium phosphate 250 mg/ 10 ml
(Maxidex (TN))		2件: Dexamethasone (Maxidex),
Phosphate ion		1件: Dexamethasone (Maxidex (TN)) 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 96 💬
35Dexamethasone sodium phosphate 250 mg/10 ml solution
(Maxidex (TN))		2件: Dexamethasone (Maxidex),
Phosphate ion		1件: Dexamethasone (Maxidex (TN)) 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 299 💬
36DEXAMETHASONE SODIUM PHOSPHATE PH. EUR.
(Maxidex (TN))		2件: Dexamethasone (Maxidex),
Phosphate ion		1件: Dexamethasone (Maxidex (TN)) 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 65 💬
37DEXAMETHASONE SODIUM SULFATE
(Maxidex (TN))		3件: Dexamethasone (Maxidex),
Sodium sulfate,
Sulfate ion		2件: Dexamethasone (Maxidex (TN)),
Sodium sulfate 💬 		1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 28 💬
38Dexamethasone soduim phosphate
(Maxidex (TN))		2件: Dexamethasone (Maxidex),
Phosphate ion		1件: Dexamethasone (Maxidex (TN)) 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 13 💬
39Dexamethasone, 40 mg
(Maxidex (TN))		1件: Dexamethasone (Maxidex)1件: Dexamethasone (Maxidex (TN)) 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 28 💬
40Dexamethasone, procarbazine
(Maxidex (TN))		2件: Dexamethasone (Maxidex),
Procarbazine		2件: Dexamethasone (Maxidex (TN)),
Procarbazine 💬 		1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 65 💬
41High dose Dexamethasone pulses
(Maxidex (TN))		1件: Dexamethasone (Maxidex)1件: Dexamethasone (Maxidex (TN)) 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 63 💬
42Intraarticular dexamethasone
(Maxidex (TN))		1件: Dexamethasone (Maxidex)1件: Dexamethasone (Maxidex (TN)) 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 46 💬
43Intravenous Dexamethasone 1 mg
(Maxidex (TN))		1件: Dexamethasone (Maxidex)1件: Dexamethasone (Maxidex (TN)) 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 46 💬
44Lenalidomide and dexamethasone
(Maxidex (TN))		2件: Dexamethasone (Maxidex),
Lenalidomide		2件: Dexamethasone (Maxidex (TN)),
Lenalidomide 💬 		2件: NR3C1,
TNF 💬 		68件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 16 💬
45Lenalidomide+Dexamethasone
(Maxidex (TN))		2件: Dexamethasone (Maxidex),
Lenalidomide		2件: Dexamethasone (Maxidex (TN)),
Lenalidomide 💬 		2件: NR3C1,
TNF 💬 		68件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 16 💬
46Lenalidomide, Dexamethasone
(Maxidex (TN))		2件: Dexamethasone (Maxidex),
Lenalidomide		2件: Dexamethasone (Maxidex (TN)),
Lenalidomide 💬 		2件: NR3C1,
TNF 💬 		68件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 16 💬
47Lenalidomide, Dexamethasone and Cyclophosphamide
(Maxidex (TN))		3件: Cyclophosphamide,
Dexamethasone (Maxidex),
Lenalidomide		4件: Cyclophosphamide ,
Dexamethasone (Maxidex (TN)),
Lenalidomide ,
Cyclophosphamide 💬 		2件: NR3C1,
TNF 💬 		68件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 28 💬
48Maxidex----1件: 53 💬
49Melphalan, thalidomide and dexamethasone
(Maxidex (TN))		3件: Dexamethasone (Maxidex),
Melphalan,
Thalidomide		3件: Dexamethasone (Maxidex (TN)),
Melphalan ,
Thalidomide 💬 		2件: NR3C1,
TNF 💬 		68件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 28 💬
50MMF and Dexamethasone
(Maxidex (TN))		1件: Dexamethasone (Maxidex)1件: Dexamethasone (Maxidex (TN)) 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 222 💬
51Peri-neural Dexamethasone 1 mg
(Maxidex (TN))		1件: Dexamethasone (Maxidex)1件: Dexamethasone (Maxidex (TN)) 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 46 💬
52Pomalidomide and Dexamethasone
(Maxidex (TN))		2件: Dexamethasone (Maxidex),
Pomalidomide		2件: Dexamethasone (Maxidex (TN)),
Pomalidomide 💬 		3件: IL6,
NR3C1,
TNF 💬 		81件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 28 💬
53Romiplostim plus dexamethasone
(Maxidex (TN))		2件: Dexamethasone (Maxidex),
Romiplostim		2件: Dexamethasone (Maxidex (TN)),
Romiplostim 💬 		2件: MPL,
NR3C1 💬 		3件: Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction 💬1件: 63 💬
54SoC: cyclophosphamide, bortezomib, and Dexamethasone (CyBorD)
(Maxidex (TN))		3件: Bortezomib,
Cyclophosphamide,
Dexamethasone (Maxidex)		4件: Cyclophosphamide ,
Dexamethasone (Maxidex (TN)),
Bortezomib ,
Cyclophosphamide 💬 		2件: NR3C1,
PSMB5 💬 		9件: Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Neuroactive ligand-receptor interaction, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬1件: 28 💬
55Venetoclax MTD with Dexamethasone
(Maxidex (TN))		2件: Dexamethasone (Maxidex),
Venetoclax		2件: Dexamethasone (Maxidex (TN)),
Venetoclax 💬 		2件: BCL2,
NR3C1 💬 		44件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Amyotrophic lateral sclerosis, Apoptosis, Apoptosis - multiple species, Autophagy - animal, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Colorectal cancer, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Epstein-Barr virus infection, Estrogen signaling pathway, Fluid shear stress and atherosclerosis, Focal adhesion, Gastric cancer, HIF-1 signaling pathway, Hedgehog signaling pathway, Hepatitis B, Herpes simplex virus 1 infection, Human immunodeficiency virus 1 infection, JAK-STAT signaling pathway, Lipid and atherosclerosis, Measles, MicroRNAs in cancer, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Necroptosis, Neuroactive ligand-receptor interaction, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platinum drug resistance, Prostate cancer, Protein processing in endoplasmic reticulum, Salmonella infection, Shigellosis, Small cell lung cancer, Sphingolipid signaling pathway, Toxoplasmosis, Tuberculosis, p53 signaling pathway 💬1件: 28 💬